Edition:
United Kingdom

Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

42.56CHF
18 Apr 2019
Change (% chg)

CHF-1.70 (-3.84%)
Prev Close
CHF44.26
Open
CHF44.30
Day's High
CHF44.30
Day's Low
CHF42.40
Volume
83,731
Avg. Vol
51,008
52-wk High
CHF73.95
52-wk Low
CHF38.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 59.47 -0.815
Jun '18 46.62 -2.074
FY 2017 Dec '17 49.51 0.111
Jun '17 41.17 -1.899
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 1 43.90 43.90 43.90 --
Quarter Ending Dec-19 2 67.65 89.30 46.00 --
Year Ending Dec-19 8 132.44 134.90 124.80 136.27
Year Ending Dec-20 8 160.37 187.50 144.90 162.90
Earnings (per share)
Quarter Ending Jun-19 2 -2.57 -2.22 -2.91 --
Quarter Ending Dec-19 2 -1.57 -0.13 -3.00 --
Year Ending Dec-19 8 -2.88 -1.83 -3.80 -0.51
Year Ending Dec-20 8 0.23 2.79 -2.33 1.38
LT Growth Rate (%) 1 -19.20 -19.20 -19.20 --
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 109.48 62.40
P/E High - Last 5 Yrs. -- 163.07 56.31
P/E Low - Last 5 Yrs. -- 52.30 28.72
Beta 1.30 1.16 0.93
Price to Sales (TTM) 4.77 46.04 9.62
Price to Book (MRQ) -- 13.22 4.53
Price to Tangible Book (MRQ) -- 18.84 7.71
Price to Cash Flow (TTM) -- 73.00 43.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.09 1.54
Dividend Yield - 5 Year Avg 0.00 0.05 0.70
Dividend 5 Year Growth Rate -- 0.72 2.97
Payout Ratio(TTM) -- 8.42 21.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 20.12 23.35 9.20
Sales (TTM) vs TTM 1 Yr. Ago 17.00 67.54 8.35
Sales - 5 Yr. Growth Rate 20.97 33.23 11.12
EPS (MRQ) vs Qtr. 1 Yr. Ago -835.06 -90.23 110.61
EPS (TTM) vs TTM 1 Yr. Ago -61.59 -- --
EPS - 5 Yr. Growth Rate -- 21.68 6.92
Capital Spending - 5 Yr. Growth Rate -12.78 25.56 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.90 2.71 2.66
Current Ratio (MRQ) 4.12 3.55 3.63
LT Debt to Equity (MRQ) -- 7.07 13.26
Total Debt to Equity (MRQ) -- 20.06 16.97
Interest Coverage (TTM) -2.56 10.02 27.27

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 80.87 25.18 50.31
Gross Margin - 5 Yr. Avg. -- 59.97 50.77
EBITD Margin (TTM) -21.01 -- --
EBITD - 5 Yr. Avg -49.76 -10.84 15.78
Operating Margin (TTM) -22.71 -109.08 -2.09
Operating Margin - 5 Yr. Avg. -52.91 -26.44 11.11
Pre-Tax Margin (TTM) -29.37 -109.66 -2.92
Pre-Tax Margin - 5 Yr. Avg. -57.36 -29.17 16.76
Net Profit Margin (TTM) -29.55 -116.04 -6.86
Net Profit Margin - 5 Yr. Avg. -57.63 -34.35 11.72
Effective Tax Rate (TTM) -- 19.91 22.86
Effective Tax Rate - 5 Yr. Avg. -- 19.61 23.86

Efficiency

  Company industry sector
Revenue/Employee (TTM) 471,520 8,511,584 773,166,387
Net Income/Employee (TTM) -139,342 1,995,061 89,056,262
Receivable Turnover (TTM) 24.36 2.36 5.22
Inventory Turnover (TTM) 1.37 2.31 3.65
Asset Turnover (TTM) 0.34 0.32 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -9.91 6.35 9.54
Return on Assets - 5 Yr. Avg. -12.62 6.24 10.49
Return on Investment (TTM) -12.88 7.96 11.78
Return on Investment - 5 Yr. Avg. -16.04 8.16 13.39
Return on Equity (TTM) -- 8.11 12.61
Return on Equity - 5 Yr. Avg. -- 9.28 14.86
  1 Year 3 Year 5 Year
Sales % 17.00 27.11 20.97
EPS (TTM) % -62.06 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Basilea Pharmaceutica AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -10.25 -11.35 99 90
13 Week -18.08 -23.70 83 74
26 Week -13.14 -20.33 99 4
52 Week -36.95 -41.82 99 26
YTD 6.51 -6.20 99 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 32.24%
# of Holders: 63
Total Shares Held: 3,830,433
3 Mo. Net Change: 117,616
# New Positions: 7
# Closed Positions: 0
# Increased Positions: 16
# Reduced Positions: 8
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.